Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023
02 Novembro 2023 - 10:00AM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) will report its third quarter 2023 financial results on
Thursday, November 9, 2023. Amylyx’ senior management team will
host a conference call and audio webcast at 8:00 a.m. ET to discuss
the financial results and other company updates.
To access the conference call, please dial (833) 816-1395 (U.S.)
or +1 (412) 317-0488 (international) at least 10 minutes prior to
the start time and ask to be joined into the Amylyx Pharmaceuticals
call. A live audio webcast of the call will be available under
“Events and Presentations” in the Investor section of the Company’s
website, https://investors.amylyx.com/news-events/events. The
webcast will be archived and available for replay for 90 days
following the event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative disease community
through the discovery and development of innovative new treatments.
Amylyx is headquartered in Cambridge, Massachusetts and has
operations in Canada and EMEA. For more information, visit
amylyx.com and follow us on LinkedIn and X, formerly known as
Twitter. For investors, please visit investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102999624/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1 (857)
320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024